Drug companies may have shorted government more than $1 billion in Medicaid rebates

January 03, 2018

Makers of just 10 drugs may have shortchanged the nation's Medicaid system by at least $1.3 billion from 2012 through 2016 by misclassifying their products in a rebate program, a government analysis found. The analysis also showed that while nearly 900 drugs may have been misclassified, in 2016 just four drugmakers were responsible for 54 percent of the potential misclassifications that led to the underpayments to the Medicaid Drug Rebate Program.